A schistosomiasis research agenda
- PMID: 18060081
- PMCID: PMC2154383
- DOI: 10.1371/journal.pntd.0000032
A schistosomiasis research agenda
Abstract
There is a long and rich history of research and control in the field of schistosomiasis that has resulted in major scientific and public health accomplishments. Examples of such findings and accomplishments include immunologic regulation in chronic infections, the association of helminth infections with Th1-regulating Th2-type immune responses, the critical role of interleukin-13 in fibrogenesis, and the development and validation of the "dose pole" for determining praziquantel dosages in the field. Perhaps in part because of this broad and successful history, those who work on schistosomiasis come from a wide variety of backgrounds and interests. While such variety is enriching to the field, it sometimes results in diverse opinions about which of the many research opportunities should be pursued. Such diversity, we believe, has at times led to a divisiveness that has harmed overall progress in the field. Partly in response to such events, we have worked with as many of those interested in schistosomiasis as we could identify to develop what we feel is a comprehensive and cohesive agenda for schistosomiasis research.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Comment in
- 
  
  The schistosomiasis research agenda--what now?PLoS Negl Trop Dis. 2008 Feb 27;2(2):e207. doi: 10.1371/journal.pntd.0000207. PLoS Negl Trop Dis. 2008. PMID: 18301729 Free PMC article. No abstract available.
References
- 
    - Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology. 2001;34:273–282. - PubMed
 
- 
    - Hall A, Nokes C, Wen S-T, Adjei S, Kihamia C, et al. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis. Trans R Soc Trop Med Hyg. 1999;93:653–658. - PubMed
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
         
               
              